- Central Labs
- Q2 Solutions
Q2 Solutions
Phone: 54 11 4556 9500
Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider. When looking for a long-term central laboratory solution, it’s important to find a partner that can accommodate your needs across a broad range of central lab services. Q2 Solutions helps sponsors enable laboratory testing in global clinical trials by providing specimen collection kits, a courier network, a biorepository, plus project management and data management. With extensive scientific expertise and industry leading capabilities in lab services, biomarkers, companion diagnostics, esoteric testing, high quality data and analytics, as well as global logistics and biorepository & specimen management, Q2 Solutions helps biotech and pharmaceutical companies meet their development needs.
For detailed contact information visit location pages below.
Q2 Solutions's locations around the world
Clinical Trials sponsored by Q2 Solutions
-
BiogenCelerion; Q2 SolutionsConcluído
-
Galvani BioelectronicsNAMSA; Q2 SolutionsRecrutamento
-
GlaxoSmithKlinePPD; ERT: Clinical Trial Technology Solutions; Q2 SolutionsRetirado
-
BiogenCelerion; Q2 Solutions; Altasciences Company Inc.ConcluídoSujeitos Adultos SaudáveisEstados Unidos
-
GlaxoSmithKlineQuintiles, Inc.; ERT: Clinical Trial Technology Solutions; Q2 Solutions; HemoCueConcluído
-
BHR Pharma, LLCQ2 Solutions; H2O Clinical LLCRescindidoCâncer de PróstataEstados Unidos
-
Vaxess TechnologiesICON plc; Q2 Solutions; Centricity ResearchConcluído
-
Entos Pharmaceuticals Inc.Q2 Solutions; Calian CRO; PCI Pharma ServicesConcluído
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncConcluídoDiabetes tipo 2Estados Unidos, Israel, Hungria, Federação Russa, México, Romênia, Reino Unido
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) e outros colaboradoresRecrutamentoCâncer de intestino | Câncer colorretal | Câncer de esôfago | NSCLC | Carcinoma Espinocelular de Cabeça e Pescoço | HNSCC | Tumores sólidos avançados/metastáticos | Câncer da junção gastroesofágicaEstados Unidos, Espanha, Bélgica, França, Holanda, Reino Unido